Condition

Skin Diseases

ClinicalTrials.gov condition label

Clinical trials12
Recruiting2
Common interventions21
Lead sponsors shown12

Clinical trials

12 shown
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUsNCT06674980 · 2024-12-20
RECRUITING
Multi-modal Quantitative Imaging of the SkinNCT06989216 · 2023-02-01
RECRUITING
Lymphaticovenous Anastomosis as Treatment for LymphedemaNCT05441943 · 2022-05-11
ACTIVE_NOT_RECRUITING
Understanding Ayurveda Disease Conditions and Treatment ResponsesNCT06167226 · 2021-12-29
COMPLETED
Groups for Specific vs Mixed Diagnosis Patients of Chronic ConditionsNCT05402358 · 2020-06-01
COMPLETED
Topical Fluorescent Nanoparticles Conjugated Somatostatin Analog for Suppression and Bioimaging Breast CancerNCT04138342 · 2019-09-15
UNKNOWN
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionNCT02682511 · 2017-01-01
ACTIVE_NOT_RECRUITING
Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCNCT01917279 · 2013-10-01
UNKNOWN
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe PsoriasisNCT01490632 · 2011-12-01
COMPLETED
The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionNCT01427400 · 2011-10-01
UNKNOWN
Studying Normal Breast Tissue and Cancer RiskNCT00341692 · 2003-04-07
COMPLETED
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerNCT00050427 · 2002-12-01
COMPLETED

Common interventions

Acceptance and Commitment Therapy Group InterventionOTHER1AM/Double - DFUOTHER1AM/Double - VLUOTHER1AM/Single - DFUOTHER1AM/Single - VLUOTHER1BaricitinibDRUG1Botulinum Toxin-ADRUG1Docetaxel plus CapecitabineDRUG1ET743DRUG1Intermittent CapecitabineDRUG1Lymphovenous anastomosisPROCEDURE1Metronomic CapecitabineDRUG1Oral IfetrobanDRUG1Oral PlaceboDRUG1Personalized Ayurveda treatment protocolDRUG1PlaceboDRUG1Quantum dots coated with veldoreotideDRUG1SalineDRUG1Standard of Care - DFUOTHER1Standard of Care - VLUOTHER1Topical approved placeboDRUG1

Trial status mix

COMPLETED5
UNKNOWN3
ACTIVE_NOT_RECRUITING2
RECRUITING2

Phase mix

PHASE23
NA2
PHASE11
PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.